During the past decade, VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 77 clinical trials were completed, i.e. on average, 89.5% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 44 clinical trials were completed. i.e. 118.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA" #1 sponsor was "VA Office of Research and Development" with 73 trials, followed by "US Department of Veterans Affairs" with 28 trials sponsored, "Eastern Cooperative Oncology Group" with 15 trials sponsored, "VA Pittsburgh Healthcare System" with 8 trials sponsored and "Gilead Sciences" with 8 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "VA Pittsburgh Healthcare System" with 10 trials as a collaborator, "University of Pittsburgh" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "Corporal Michael J. Crescenz VA Medical Center" with 3 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA" are "Heart Failure" (9 trials), "Prostate Cancer" (8 trials), "Colorectal Cancer" (5 trials), "Insomnia" (5 trials) and "Lung Cancer" (5 trials). Many other conditions were trialed in "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA" in a lesser frequency.

Most popular intervention types in "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA" are "Drug" (80 trials), "Other" (38 trials), "Behavioral" (36 trials), "Device" (29 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Docetaxel" (4 trials), "Bevacizumab" (3 trials), "Laboratory Biomarker Analysis" (3 trials) and "Prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA" are 189 trials for "All" genders, 10 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 45 active trials in "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA". 4 are not yet recruiting, 26 are recruiting, 13 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 139 completed trials in VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, 5 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 77 trials that are defined as “Not Applicable".